2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol, 98%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylbutanoic acid, 95.0%, 1g

4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)morpholine, 97.0%, 1g

N,N-DIETHYL-2-(2-HYDROXY-2,2-DIPHENYLACETOXY)-N-METHYLETHANAMINIUM BROMIDE, 95%, 10g

6-Oxaspiro[2.5]octan-1-amine hydrochloride, 1g

Methyl 4-aminothiophene-3-carboxylate hydrochloride, 95.0%, 10g

Imipramine hydrochloride, 95.0%, 25g

Sodium chloride >99%, 99.0%, 2kg

ETHYL 2-(3-CYANOOXETAN-3-YL)ACETATE, 95.0%, 250mg

2-(6,7-dichloro-1H-1,3-benzodiazol-2-yl)-5-methyl-4-(3-oxo-1,3-dihydro-2-benzofuran-1-yl)-2,3-dihydro-1H-pyrazol-3-one, 98%, 10mg

3-nitro-2-(phenylamino)benzoic acid, 95.0%, 5g

2-Thiomethyl-4-bromothiazole, 95.0%, 250mg

Alloy according to Devarda, pa, 500 g, glass packaging